drugset / Trial / NCT02344316

Bringing Relief to Adolescents Naturally Using Melatonin for Migraine

NCT02344316

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Migraine in adolescents is common and effective and safe preventive treatments are needed. This is a pilot randomized controlled trial of melatonin versus placebo for migraine prevention in adolescents 12-17 years old.

Timeline

Start
2015-05
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 3 mg Oral

Indications

No indication recorded.